BPC-157

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide corresponding to a partial sequence identified within human gastric juice, extensively studied in preclinical models of tissue repair, angiogenesis, and gut-brain axis signaling.

Published rodent and in-vitro studies have examined BPC-157's interaction with growth-factor signaling pathways (including VEGFR2), nitric-oxide system modulation, and fibroblast migration assays relevant to wound-healing research models.

• TB-500 — a related compound frequently studied alongside BPC-157 in comparative research designs.

For in-vitro assay preparation, researchers calculate a target concentration (mg/mL) from the vial's labeled mass and the volume of sterile diluent added, then aliquot and store per standard laboratory cold-chain practice. This is a laboratory dilution calculation only, performed strictly for analytical or in-vitro research purposes. Not for use in humans or animals.

Lyophilized powder should be stored at -20°C for long-term stability, or refrigerated (2-8°C) for short-term use, protected from light and moisture. Once reconstituted for laboratory use, follow standard cold-chain handling and use within the timeframe indicated by your institution's protocols.

BPC-157 ships with a QR-linked, batch-specific certificate of analysis (COA) confirming identity and purity via HPLC. Researchers should always confirm the lot number on their vial matches the COA on file before beginning any assay.

This reference material is manufactured and quality-tested to support reproducible research outcomes. Every batch is independently verified before it ships, and COAs remain accessible for future reference.